| __timestamp | Axsome Therapeutics, Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4279200 | 79838000 |
| Thursday, January 1, 2015 | 6776987 | 121816000 |
| Friday, January 1, 2016 | 21199860 | 117633000 |
| Sunday, January 1, 2017 | 19957616 | 117456000 |
| Monday, January 1, 2018 | 23495055 | 171984000 |
| Tuesday, January 1, 2019 | 53647067 | 257452000 |
| Wednesday, January 1, 2020 | 70244579 | 477643000 |
| Friday, January 1, 2021 | 58060725 | 540684000 |
| Saturday, January 1, 2022 | 57947447 | 651496000 |
| Sunday, January 1, 2023 | 97944000 | 666563000 |
| Monday, January 1, 2024 | 187077000 |
Unleashing the power of data
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, Axsome Therapeutics, Inc. and PTC Therapeutics, Inc. have demonstrated a steadfast commitment to research and development (R&D), a critical driver of their growth and innovation.
Since 2014, Axsome Therapeutics has increased its R&D spending by over 2,000%, reflecting its aggressive pursuit of novel therapies. By 2023, their R&D expenses reached nearly $98 million, a testament to their dedication to advancing mental health treatments.
PTC Therapeutics, on the other hand, has consistently invested in R&D, with a 735% increase over the same period. Their 2023 R&D expenditure of approximately $667 million underscores their focus on rare genetic disorders.
Both companies exemplify the biotech industry's relentless drive towards innovation, with R&D investments that have grown significantly over the years.
Who Prioritizes Innovation? R&D Spending Compared for Novo Nordisk A/S and PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Axsome Therapeutics, Inc.
Comparing Innovation Spending: Bristol-Myers Squibb Company and PTC Therapeutics, Inc.
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs PTC Therapeutics, Inc.
R&D Spending Showdown: Genmab A/S vs Axsome Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Axsome Therapeutics, Inc. and TG Therapeutics, Inc.
Research and Development Investment: Axsome Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
R&D Insights: How PTC Therapeutics, Inc. and Xencor, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.